Related references
Note: Only part of the references are listed.Inflammatory cytokines, high-sensitivity C-reactive protein, and risk of one-year vascular events, death, and poor functional outcome after stroke and transient ischemic attack
S. Coveney et al.
INTERNATIONAL JOURNAL OF STROKE (2022)
Circulating Interleukin-6 Levels and Incident Ischemic Stroke A Systematic Review and Meta-analysis of Prospective Studies
Andreas Papadopoulos et al.
NEUROLOGY (2022)
Colchicine for prevention of vascular inflammation in Non-CardioEmbolic stroke (CONVINCE) - study protocol for a randomised controlled trial
Peter Kelly et al.
EUROPEAN STROKE JOURNAL (2021)
Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease
Meng Xia et al.
AMERICAN JOURNAL OF CARDIOLOGY (2021)
Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years
John Joseph McCabe et al.
NEUROLOGY (2021)
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials
Aernoud T. L. Fiolet et al.
EUROPEAN HEART JOURNAL (2021)
From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?
Paul M. Ridker
CARDIOVASCULAR RESEARCH (2021)
Inflammation and Stroke Risk: A New Target for Prevention
Peter J. Kelly et al.
STROKE (2021)
Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis
J. J. McCabe et al.
EUROPEAN STROKE JOURNAL (2021)
Intra- and extra-hospital improvement in ischemic stroke patients: influence of reperfusion therapy and molecular mechanisms
Pablo Hervella et al.
SCIENTIFIC REPORTS (2020)
Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2020)
Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults
Yiping Chen et al.
Lancet Global Health (2020)
Inflammatory Response of Ischemic Tolerance in Circulating Plasma: Preconditioning-Induced by Transient Ischemic Attack (TIA) Phenomena in Acute Ischemia Patients (AIS)
Laura Colas-Campas et al.
FRONTIERS IN NEUROLOGY (2020)
Comparison of interteukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2020)
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke: Role of Monocyte Chemoattractant Protein-1
Marios K. Georgakis et al.
CIRCULATION (2019)
Long-Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta-Analysis
Marion Boulanger et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The determination of copeptin levels helps management decisions among transient ischaemic attack patients
F. Purroy et al.
ACTA NEUROLOGICA SCANDINAVICA (2016)
Inflammatory Markers and Outcomes After Lacunar Stroke Levels of Inflammatory Markers in Treatment of Stroke Study
Amelia K. Boehme et al.
STROKE (2016)
High-Sensitive C-Reactive Protein Predicts Recurrent Stroke and Poor Functional Outcome Subanalysis of the Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events Trial
Jiejie Li et al.
STROKE (2016)
Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke
Annie Pedersen et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation
Julia Aulin et al.
AMERICAN HEART JOURNAL (2015)
Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data The PRISMA-IPD Statement
Lesley A. Stewart et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Lipids and Cerebrovascular Disease Research and Practice
Shadi Yaghi et al.
STROKE (2015)
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
Stephen Kaptoge et al.
EUROPEAN HEART JOURNAL (2014)
C-Reactive Protein as a Prognostic Marker After Lacunar Stroke Levels of Inflammatory Markers in the Treatment of Stroke Study
Mitchell S. V. Elkind et al.
STROKE (2014)
Population-Based Study of Blood Biomarkers in Prediction of Subacute Recurrent Stroke
Helen C. Segal et al.
STROKE (2014)
An Updated Definition of Stroke for the 21st Century A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Ralph L. Sacco et al.
STROKE (2013)
Association of Circulating Inflammatory Markers With Recurrent Vascular Events After Stroke A Prospective Cohort Study
William Whiteley et al.
STROKE (2011)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
Stephen Kaptoge et al.
LANCET (2010)
Interconversion of the National Institutes of Health Stroke Scale and Scandinavian Stroke Scale in Acute Stroke
Laura J. Gray et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2009)
C-reactive protein predicts further ischemic events in transient ischemic attack patients
F. Purroy et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Evaluation of the quality of prognosis studies in systematic reviews
JA Hayden et al.
ANNALS OF INTERNAL MEDICINE (2006)
Inflammation as a risk factor for atrial fibrillation
RJ Aviles et al.
CIRCULATION (2003)
Inflammation and thrombosis
CT Esmon
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report
SM Grundy et al.
CIRCULATION (2002)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)